It has been shown before that leucine and isoleucine alleviate obesity- and HFD-induced hepatic steatosis in mice by inducing PLIN2 ubiquitination degradation via activating UBR1/2 [27]. The gene discussed is UBR1; the disease is fatty liver disease.